Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-09

FDA Approved: CARBOPROST TROMETHAMINE — Original Application (Long Grove Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a generic carboprost tromethamine from Long Grove Pharmaceuticals, LLC under an original ANDA. The approval covers indications for second-trimester…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)

Snippet

ORIG AP for CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)